This most recent twist within the Lykos Therapeutics saga threatens a major overhaul of the business’s method and direction, with Musk ally and billionaire Trader Antonio Gracias appearing to need to take the corporation back towards its nonprofit drug advancement roots and a far more Doblinite philosophy.Are you wanting to take a journey outside